DHEA After 40: Does Supplementing the "Youth Hormone" Make Sense?

DHEA (dehydroepiandrosterone) and its storage form, DHEA-S, are the most abundant circulating steroid hormones in the human body, produced mainly by the adrenal cortex. They act as a precursor — a raw material from which peripheral tissues can synthesize both testosterone and estrogens, depending on local demand. This sets DHEA apart from typical "end" hormones and makes its effects harder to predict than direct testosterone or estrogen supplementation.

DHEA levels peak around age 25, then decline steadily — a phenomenon sometimes called "adrenopause," by analogy with menopause or andropause. By age 70-80, DHEA levels can be 80-90% lower than at their peak. It's precisely this dramatic, universal, and easily measurable decline that made DHEA an attractive candidate for an "anti-aging hormone" — in the United States, DHEA is classified as an over-the-counter dietary supplement, while in most of Europe it requires a prescription as a drug-like product.

The most rigorous test of the "DHEA as an anti-aging hormone" hypothesis was a randomized trial published in the New England Journal of Medicine, led by a team from the Mayo Clinic.

The NEJM trial, though rigorous, is just one data source. It's worth checking whether its conclusions hold up in a broader meta-analysis pooling multiple randomized trials in men.

This meta-analysis's conclusion is precise and worth remembering: DHEA may produce a small, beneficial effect on body composition, but only to the extent it's converted in the body into active hormones (androgens or estrogens) — supplementing "raw" DHEA itself, without that conversion, has no independent effect on these parameters. This is an important distinction between "DHEA itself" and "the products of its metabolism."

The picture isn't entirely uniformly negative, though. The French DHEAge trial, one of the first large, year-long randomized trials on DHEA, showed some benefits — though limited to a specific subgroup.

This distinction matters in the broader conversation about hormones after 40 — we cover declining testosterone levels in men with age and their accompanying symptoms more broadly in our entry on andropause, where we also show that not every hormonal decline warrants a pharmacological or supplemental intervention.

Even though DHEA is sold over the counter as a dietary supplement in the United States, pharmacologically it behaves like a hormonal precursor, not an inert nutrient — carrying specific risks that typical vitamins or minerals don't.

Based on the full body of evidence, it's hard to identify a broad group of healthy people over 40 or 50 for whom DHEA supplementation would have strongly justified, wide-ranging benefits. The only narrowly defined context where a single trial showed concrete benefits is older women (over 70) in terms of libido, skin condition, and bone turnover — and even that rests on one trial not fully confirmed by later, larger studies. Anyone considering supplementation should first discuss it with an endocrinologist, ideally after basic hormonal testing, rather than reaching for DHEA as a general "anti-aging supplement" without an indication.

DHEA is a good example of how easy it is to mistake a hormone's age-related decline for an automatic indication to supplement it. The mere fact that something declines with age doesn't mean replacing it will reverse the accompanying changes of aging — and the best available, rigorous randomized trial directly fails to confirm this for strength, body composition, and insulin sensitivity. The few confirmed benefits are narrow, limited to a specific subgroup (older women) and specific parameters, not a general "rejuvenation."